An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on…

Read more »

The post Final U.S. Hurdle for Merck’s COVID-19 Pill: FDA Panel Review appeared first on Hamodia.

In related news:

  1. How a Discovery Could Help Those Battling the Coronavirus
  2. Gilead Disputes Report That Its Drug Flopped in Coronavirus Trial
  3. WHO: ‘No Evidence’ That Recovered COVID-19 Patients Cannot be Reinfected
  4. WHO Looks at Possible ‘E-Vaccination Certificates’ for Travel
  5. COVID-19 Vaccines Aren’t Perfect, But They’re Very, Very Effective